Search

Author/Creator Cheson, Bruce D

11. Safety and tolerability of idelalisib, lenalidomide, and rituximab in relapsed and refractory lymphoma: the Alliance for Clinical Trials in Oncology A051201 and A051202 phase 1 trials. Issue 4 (April 2017)

Authors:
Smith, Sonali M; Pitcher, Brandelyn N; Jung, Sin-Ho; Bartlett, Nancy L; Wagner-Johnston, Nina; Park, Steven I; Richards, Kristy L; Cashen, Amanda F; Jaslowski, Anthony; Smith, Scott E; Cheson, Bruce D; Hsi, Eric; Leonard, John P
Journal:
Lancet
Issue:
Volume 4:Issue 4(2017)
Page Start:
e176
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

14. Venetoclax for chronic lymphocytic leukaemia progressing after ibrutinib: an interim analysis of a multicentre, open-label, phase 2 trial. Issue 1 (January 2018)

Authors:
Jones, Jeffrey A; Mato, Anthony R; Wierda, William G; Davids, Matthew S; Choi, Michael; Cheson, Bruce D; Furman, Richard R; Lamanna, Nicole; Barr, Paul M; Zhou, Lang; Chyla, Brenda; Salem, Ahmed Hamed; Verdugo, Maria; Humerickhouse, Rod A; Potluri, Jalaja; Coutre, Steven; Woyach, Jennifer; Byrd, ...
Journal:
Lancet oncology
Issue:
Volume 19:Issue 1(2018)
Page Start:
65
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗